4 results
1. To determine the safety and tolerability of TMC649128/TMC619688 during multiple dosing in treatmentnaïve and treatment-experienced genotype 1 HCV-infected subjects at different dose regimens as 10-days and 14-days monotherapy.2. To determine the…
The aim of the study is to confirm efficacy and safety of treatment with 600 mg of BID BI207127 in combination with 120 mg QD Faldaprevir and RBV for 16 and 24 weeks in target chronically infected HCV GT1b treatment naïve patients, including a…
The study objected to tree hypotheses which had to be evaluated: speech intelligibility is dependent of type of background noise, speech intelligibility is dependent of the noise level, and compression can improve the speech intelligibility in…
to evaluate the effect of hearing aid fitting as a treatment for tinnitus in patients with mild hearing losses and to determine factors that are critical to this effect.